Ultrahuman M2 Live Launches
Ultrahuman launches M2 Live, a $99/month health platform offering continuous glucose monitoring without a prescription, using Abbott's Lingo CGM
Key points
- Ultrahuman, a health tech company, has launched its M2 Live platform, offering continuous glucose monitoring without a prescription
- The platform uses Abbott's over-the-counter Lingo CGM, priced at $129 for a single sensor or $99/month for a subscription
- M2 Live integrates with the Ultrahuman Ring to provide in-depth metabolic insights, including a clinically validated Metabolic Score
- The platform is set to launch in the US in the coming weeks, making continuous glucose monitoring more accessible and affordable
- Ultrahuman's AI, Jade, will analyze data from the Lingo CGM and the Ultrahuman Ring to offer personalized guidance and insights
- The launch of M2 Live marks a significant development in the health tech industry, making continuous glucose monitoring more accessible to a wider audience
Ultrahuman has launched its M2 Live health platform, offering continuous glucose monitoring without a prescription. The platform uses Abbott's over-the-counter Lingo CGM, which can be purchased for $129 or subscribed to for $99/month. M2 Live integrates with the Ultrahuman Ring to provide in-depth metabolic insights, including a clinically validated Metabolic Score. The platform is set to launch in the US in the coming weeks, making continuous glucose monitoring more accessible and affordable. Ultrahuman's AI, Jade, will analyze data from the Lingo CGM and the Ultrahuman Ring to offer personalized guidance and insights. The launch of M2 Live marks a significant development in the health tech industry, making continuous glucose monitoring more accessible to a wider audience.
Sources
The WireByte editorial team synthesises technology news from multiple primary sources, verifies the facts, and links every source. Articles are produced with AI assistance and reviewed under our editorial policy.